Compare RNXT & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | PODC |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 56.5M |
| IPO Year | 2021 | N/A |
| Metric | RNXT | PODC |
|---|---|---|
| Price | $1.03 | $2.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 202.4K | 34.4K |
| Earning Date | 11-13-2025 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $928,000.00 | ★ $56,957,000.00 |
| Revenue This Year | $2,795.35 | $17.39 |
| Revenue Next Year | $272.69 | $19.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 20.01 |
| 52 Week Low | $0.70 | $1.28 |
| 52 Week High | $1.69 | $2.94 |
| Indicator | RNXT | PODC |
|---|---|---|
| Relative Strength Index (RSI) | 61.75 | 58.92 |
| Support Level | $0.84 | $1.98 |
| Resistance Level | $0.92 | $2.63 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 96.30 | 74.24 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.